129 related articles for article (PubMed ID: 5983598)
1. [Identification of antithrombin V and its behavior in the plasma and serum of the newborn infants and adults].
Brüster H; Sturm H
Z Kinderheilkd; 1966; 95(1):24-8. PubMed ID: 5983598
[No Abstract] [Full Text] [Related]
2. Assay of progressive antithrombin in plasma.
Abildgaard U; Gravem K; Godal HC
Thromb Diath Haemorrh; 1970 Oct; 24(1):224-9. PubMed ID: 5483962
[No Abstract] [Full Text] [Related]
3. [Studies on the process of fibrinogen breakdown by plasmin. II. Relationship between serial thrombin time and plasma antithrombin or antiplasmin].
Shinada S
Nihon Naika Gakkai Zasshi; 1970 Sep; 59(9):959-66. PubMed ID: 4248531
[No Abstract] [Full Text] [Related]
4. Exchange transfusion activates coagulation and alters the coagulation profile in newborn infants.
Långström S; Wartiovaara-Kautto U; Andersson S; Heikinheimo M; Petäjä J
Thromb Haemost; 2006 Aug; 96(2):142-8. PubMed ID: 16894456
[TBL] [Abstract][Full Text] [Related]
5. Coagulation studies of the vascular intima. II. Antithrombin activity.
Oe K
Nihon Ketsueki Gakkai Zasshi; 1969 Apr; 32(2):297-310. PubMed ID: 5388239
[No Abstract] [Full Text] [Related]
6. [Behavior of thrombin time, activities of antithrombin II and 3 following administration of cobalt (II) compounds in rabbits].
Wohllebe W; Taube C; Fiedler H
Z Gesamte Inn Med; 1968 Sep; 23(17):537-9. PubMed ID: 5715725
[No Abstract] [Full Text] [Related]
7. [Coagulation parameters in mother and newborn infant].
Biland L; Duckert F
Schweiz Med Wochenschr; 1972 Nov; 102(44):1611-2. PubMed ID: 4645049
[No Abstract] [Full Text] [Related]
8. [Hypercoagulability in atrial fibrillation and its relationship with risk factors for systemic embolism].
Pérez LA; Corbalán R; Acevedo M; Pereira J; Braun S; Tapia J; Kramer A; Lira MT; Huete I; Sepúlveda G; Springmüller D
Rev Med Chil; 2002 Oct; 130(10):1087-94. PubMed ID: 12491825
[TBL] [Abstract][Full Text] [Related]
9. Activated coagulation factors in human malignant effusions and their contribution to cancer cell metastasis and therapy.
Gieseler F; Lühr I; Kunze T; Mundhenke C; Maass N; Erhart T; Denker M; Beckmann D; Tiemann M; Schulte C; Dohrmann P; Cavaillé F; Godeau F; Gespach C
Thromb Haemost; 2007 Jun; 97(6):1023-30. PubMed ID: 17549306
[TBL] [Abstract][Full Text] [Related]
10. [Thrombotest and the level of some plasma factors in newborn infants].
Witt C; Polaczek K; Lacki L; Koziol A
Pediatr Pol; 1977 May; 52(5):483-8. PubMed ID: 882335
[No Abstract] [Full Text] [Related]
11. [Reliability of reptilase and thrombin coagulase coagulation times for measurement of antithrombin VI activity with reference to immunoelectrophoretic characteristics of various fibrinogen and fibrin fission products].
Stürner KH; Holzhüter H; Ochs HG; Angelkort B; Muchietti F; Wenzel E
Verh Dtsch Ges Inn Med; 1973; 79():1328-30. PubMed ID: 4790173
[No Abstract] [Full Text] [Related]
12. Do coagulation screening tests detect increased generation of thrombin and plasmin in sick newborn infants?
Schmidt B; Vegh P; Johnston M; Andrew M; Weitz J
Thromb Haemost; 1993 May; 69(5):418-21. PubMed ID: 8322263
[TBL] [Abstract][Full Text] [Related]
13. A tanned red cell hemagglutination inhibition immunoassay (TRCHII) for the quantitative estimation of thrombin-antithrombin III and plasmin-alpha1-antiplasmin complexes in human plasma.
Collen D; De Cock F
Thromb Res; 1975 Jul; 7(1):235-8. PubMed ID: 125465
[No Abstract] [Full Text] [Related]
14. Hemostasis in plasmocytomas. Preliminary observations on the inhibiting activities demonstrable in the plasma and serum protein fractions.
Recalcati P; Besana C; Ballarino M
Haematol Lat; 1967; 10(4):317-35. PubMed ID: 5597878
[No Abstract] [Full Text] [Related]
15. Implications of depressed antithrombin-3 activity associated with oral contraceptives.
Zuck TF; Bergin JJ; Raymond JM; Dwyre WR
Surg Gynecol Obstet; 1971 Oct; 133(4):609-12. PubMed ID: 5096309
[No Abstract] [Full Text] [Related]
16. Coagulation studies in chronically bedridden patients.
Lorentsen E; Eika C; Godal HC
Acta Med Scand; 1974; 195(1-2):79-80. PubMed ID: 4817096
[No Abstract] [Full Text] [Related]
17. [Antithrombin V--a rare concomitant symptom in plasmacytoma and autoimmune diseases].
Lutze G; Dieckmann U; Franke A; Mittler U
Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(2):278-92. PubMed ID: 6194061
[TBL] [Abstract][Full Text] [Related]
18. [Modification of the coagulation potential of immature newborn infants with AB-plasma concentrate and PPSB-fraction].
Rogner G
Kinderarztl Prax; 1969 Sep; 37(9):390-400. PubMed ID: 5398360
[No Abstract] [Full Text] [Related]
19. [Effect of long-term plasmapheresis on blood composition. II. Changes in the concentration of coagulation factors, inhibitors, thrombocytes and its effect on routine tests of coagulation].
Grgicević D
Bilt Hematol Transfuz; 1981; 9(1-3):89-100. PubMed ID: 7349762
[TBL] [Abstract][Full Text] [Related]
20. [Changes in blood coagulation in the infant with severe malnutrition without manifestations of bleeding or infection].
Izquierdo-Ramírez J; Watanabe-Sayto C; Franco-Vega G; Espinosa-Huerta E; Marín-Palomares T; Dueñas-González MT
Bol Med Hosp Infant Mex; 1988 Jun; 45(6):347-52. PubMed ID: 3139008
[No Abstract] [Full Text] [Related]
[Next] [New Search]
